Clinical trial
Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to…
NCT00335686 · Germans Trias i Pujol Hospital, Other · Completed
Key facts
| NCT number | NCT00335686 |
|---|---|
| Title | Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients |
| Official title | Randomised, Prospective Multicentre Clinical Study on the Effect of the Combination of Lopinavir/Rtv + Nevirapine as Maintenance Bitherapy (Without Nucleoside Analogues) in Comparison With a Triple Therapy Including Lopinavir/Rtv + Nucleoside Analogues in HIV-Infected Patients |
| Lead sponsor | Germans Trias i Pujol Hospital, Other |
| Collaborators | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Lopinavir-rtv (Kaletra): 3 capsules (600 mg)/12 h, Nevirapine (Viramune): 1 comp (200mg)/12h |
| Enrollment | 67 |
| Start date | Oct 1, 2003 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Jun 12, 2006 |
| Last update posted | Feb 29, 2008 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: